Lu-Ann Murdoch
ARTICLES BY THIS AUTHOR
- 10/3/2022
Alberta pharmacists develop DOAC drug interactions management resource
Practice a tool compares drug interactions with the four marketed DOACs, focusing on interactions commonly encountered in thrombosis/cardiology-based practices - 9/28/2022
Updated interim guidance on using Imvamune vaccine for mpox outbreaks
NACI includes recommendation to use one-fifth the usual dose intradermally (off-label) for the second pre-exposure vaccination dose, in times of limited vaccine supply. - 9/26/2022
POP QUIZ: Intrarosa for postmenopausal vaginal atrophy
Intrarosa is a new treatment for postmenopausal vulvovaginal atrophy. All of the following statements about Intrarosa are true, EXCEPT for . . . - 9/26/2022
Evidence-based suggestions to promote antibiotic stewardship in dermatology
Strategies healthcare providers can use to reduce the development of antibiotic resistance in common dermatologic conditions. - 9/22/2022
Biosimilars now considered interchangeable in the European Union
Biosimilars are interchangeable with the reference medicine and with other equivalent biosimilars. - 9/19/2022
Pharmacist intervention can improve clinical outcomes in ulcerative colitis
Study investigates the impact of pharmacist intervention on medication adherence and clinical outcomes in patients with ulcerative colitis. - 9/14/2022
POP QUIZ: GLP-1 agonists and SGLT2 inhibitors for cardiorenal risk reduction
Test your drug knowledge! - 9/14/2022
Can school-aged children accurately self-collect nasal swabs for SARS-CoV-2 tests?
Study compares results of nasal swabs for SARS-CoV-2 testing self-collected by children and adolescents with those collected by healthcare workers - 9/12/2022
How effective are COVID-19 vaccines in preventing hospitalization?
Large U.S. study compares hospitalization rates in unvaccinated, vaccinated and vaccinated plus booster dose individuals - 9/7/2022
Psychological distress may be a risk factor for post-COVID-19 conditions
Depression, anxiety, worry, perceived stress or loneliness preceding SARS-CoV-2 infection may increase risk of developing “long” COVID symptoms.
